ALTO Alto Ingredients, Inc. Insider Trading

Director Gilbert E Nathan purchases 25.0K shares for $114.4K; stock up 73.9% in 90 days on improved fundamentals

Director Gilbert E Nathan acquired 25,000 shares for $114,450.00, bringing his post-transaction holdings to 774,741 shares. This purchase occurs as ALTO trades at $4.66, down 22.3% from its 52-week high of $6.00 but significantly outperforming the broader trend with a 90-day gain of 73.9%. Nathan's track record supports credibility: his 17 prior buys averaged 90-day returns of +35.7% with a 100% win rate over that period, though recent 30-day performance has softened at +0.8%. The company shows stabilizing fundamentals with net income of $4.3M on revenue of $224.7M and a rational P/E of 12.26, though annual revenue contracted 4.9%. The purchase signal carries weight given Nathan's consistent buy-then-outperformance pattern and his substantial existing stake, suggesting conviction despite near-term headwinds and the stock's recent pullback from highs.

Chief Commercial Officer James R Sneed purchases 3,176 shares of ALTO at $1.06 amid -21.1% annual revenue decline and unprofitability

James R Sneed, Chief Commercial Officer of Alto Ingredients, purchased 3,176 shares at $1.06 on 2025-08-13, a modest addition representing less than 1% of his pre-transaction holdings of 429,221 shares. The purchase occurs in a deteriorating fundamental backdrop: the company reported -$10,997,000 net income over its most recent full fiscal year, annual revenue declined -21.1% year-over-year, and the stock has fallen -46.4% from its 52-week high of $1.94, now trading at $1.04 (below the transaction price within days). The relatively small transaction size and limited incremental weight suggest this is not a substantial conviction signal. An investor should note the fundamental weakness—sustained unprofitability and sharp revenue contraction—in context of any insider purchase, particularly one of this magnitude.

Director Nathan Gilbert buys 30,000 shares at $1.34 avg; holdings jump 2500% amid cluster buy & prior strong timing

Nathan Gilbert E, a director at Alto Ingredients, purchased 2 separate tranches totaling 30,000 shares for $40,100.00 on 2024-11-13, expanding his holdings from 1,200 to 31,200 shares—a 2500.0% increase. The timing pattern warrants attention: his 2 prior buys at ALTO (both in May/June 2023) were well-timed at the 90-day mark, with 90d returns of +83.2% and +78.4%, suggesting a demonstrated ability to identify entry points at this company. This current purchase arrives as a cluster buy, with 2 other insiders also buying within the past 14 days. However, the stock is trading at $1.37 against a 52-week high of $2.94 (down 53.4%), and the company remains unprofitable with latest-quarter net income of $-2.4M and annual revenue declining 8.4%, creating an uncertain backdrop despite the insider accumulation signal.

CFO Olander buys 7,350 ALTO shares at $1.36; 2 other insiders bought in past 14 days amid -55.4% slide from 52-week high.

Robert R. Olander, CFO of Alto Ingredients, purchased 7,350 shares at $1.36 on 2024-11-12, increasing his holdings by 3.4% to 225,056 shares. This purchase occurred amid significant downward price pressure: the stock is -55.4% from its 52-week high and has declined 19.1% over the past 30 days. A cluster pattern emerges—two other insiders also bought within the past 14 days—suggesting coordinated response to recent weakness rather than isolated opportunistic trading. The company's fundamentals are deteriorating: latest quarterly revenue is $251,814,000 but net income is negative at $-2,441,000, with annual revenue growth at -8.4% and the company unprofitable over its most recent full fiscal year. The confluence of multiple insider purchases during a sustained decline, combined with fundamental headwinds, warrants attention to whether this represents conviction or a required response to market conditions.

CEO McGregor bought 37,000 shares ($50.4K) at $1.36; stock down 55.4% from 52-week high; cluster of 2 other insider buys in 14 days

McGregor Bryon T, President & CEO, purchased 37,000 shares at $1.36, adding 4.6% to his holdings now totaling 834.3K shares. This transaction occurs within a cluster pattern—2 other insiders also bought within the past 14 days—suggesting coordinated confidence at current levels. However, the stock has declined 55.4% from its 52-week high of $2.94 and the company is unprofitable, with net income of $-2.4M on quarterly revenue of $251.8M and annual revenue contraction of -8.4%. The CEO's accumulation against a backdrop of operational losses and sharply depressed valuation merits scrutiny of the company's turnaround plans and whether management sees near-term catalysts not yet reflected in market pricing.